MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

To control the coronavirus disease 2019 (COVID-19) pandemic and the emergence of different variants of concern (VoCs), novel vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed. In this study, we report the potent immunogenicity and efficacy induced in hamsters b...

Full description

Bibliographic Details
Main Authors: Robbert Boudewijns, Patricia Pérez, Adrián Lázaro-Frías, Dominique Van Looveren, Thomas Vercruysse, Hendrik Jan Thibaut, Birgit Weynand, Lotte Coelmont, Johan Neyts, David Astorgano, Dolores Montenegro, Eugenia Puentes, Esteban Rodríguez, Kai Dallmeier, Mariano Esteban, Juan García-Arriaza
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
COVID-19
MVA vaccine
spike
hamsters
immunogenicity
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.845969/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.845969/full

Similar Items